SEC Filing Details
Jan 16, 2020
Jan 15, 2020
Report of unscheduled material events or corporate event
KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.